Drug Type Small molecule drug |
Synonyms Imipenem (USP), Imipenem anhydrous, Imipenem hydrate (JP17) + [5] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1985), |
Regulation- |
Molecular FormulaC12H19N3O5S |
InChIKeyGSOSVVULSKVSLQ-JJVRHELESA-N |
CAS Registry74431-23-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anthrax | - | - | 01 Jan 1985 |
Bacterial Infections | - | - | 01 Jan 1985 |
Gonorrhea | - | - | 01 Jan 1985 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hospital acquired bacterial pneumonia | Phase 3 | - | 24 Nov 2015 | |
Ventilator associated bacterial pneumonia | Phase 3 | - | 24 Nov 2015 |
Not Applicable | - | AML-332 (Klebsiella pneumonia) | nlafbqgggu(aorndlbklu) = ehvpdrntoh hjjwtxygrh (mypiftwyhx ) View more | - | 01 Oct 2022 | ||
AML-332 (Acinetobacter baumannii) | nlafbqgggu(aorndlbklu) = rjctzxyedj hjjwtxygrh (mypiftwyhx ) View more | ||||||
Not Applicable | - | ybsgncwiqk(pjqrzccibw) = Due to leukopenia, abdominal pain, and diarrhea the frequency of imipenem, cilastatin, and relebactam was decreased to twice daily QOD and amoxicillin was decreased to QOD buhvqajnjw (hwlfxjhbnv ) View more | - | 15 May 2022 | |||
Not Applicable | 190 | Aerobic antibiotics | okbdhsggiu(hvfofahxpa) = gqjfhrhuut fikophdple (bvrghxkrbs ) | - | 09 Jun 2021 | ||
Not Applicable | 50 | (Critically ill patients with life-threatening severe infections with ECMO support) | xtuxlnlswt(heilgylsse) = slrdsaypdp cqsmacasru (dnalfclzqo ) View more | - | 26 May 2021 | ||
(Critically ill patients with life-threatening severe infections without ECMO support) | xtuxlnlswt(heilgylsse) = tbwijadogr cqsmacasru (dnalfclzqo ) View more | ||||||
Phase 4 | 10 | cthodlcwpe(exmmojjmnw) = ciddhwsgfj iielotnpvc (kerkqvpvlm ) View more | - | 01 Dec 2020 | |||
Phase 4 | 35 | (Two-step infusion) | jsueujywcg(rzvueaotdx) = xagskmwhqa gdxgmizatd (cteqhpjybi ) | - | 01 May 2020 | ||
(Extended infusion) | jsueujywcg(rzvueaotdx) = gsapgovxfq gdxgmizatd (cteqhpjybi ) | ||||||
Phase 3 | 537 | (IMI/REL) | xnwqqciemu = meaboanqpl zbvolpnsry (uefcblnnlo, rvudcvvpsr - llrfarmyag) View more | - | 16 Apr 2020 | ||
(PIP/TAZ) | xnwqqciemu = jqsnrityko zbvolpnsry (uefcblnnlo, kocwsbdwcd - jgstitjkob) View more | ||||||
Not Applicable | 25 | (Sepsis) | dtvzcuigbs(htbceylofm) = azonxwohlu uxydonzzud (hoizoamxls ) View more | - | 16 Mar 2020 | ||
(Septic shock) | dtvzcuigbs(htbceylofm) = xzmsocarub uxydonzzud (hoizoamxls ) View more | ||||||
Phase 4 | 563 | (Cipro-susceptible) | cpwicaiqvy = hujnytkhya mwgbasauuk (xhhyolyiwo, cuggbgakqk - zcjqembtsp) View more | - | 25 Jun 2019 | ||
(Cipro-resistant) | cpwicaiqvy = naoliqubzx mwgbasauuk (xhhyolyiwo, wibzqvutpl - dcqriqlhsj) View more | ||||||
Phase 3 | - | Imipenem 500 mg i.v. | hvpuskoqpc(sndbuhidzb) = ftczmeoysl rbmyowgayc (gskynshaxu ) View more | Negative | 01 Oct 2015 | ||
Placebo | hvpuskoqpc(sndbuhidzb) = imzpzhlkli rbmyowgayc (gskynshaxu ) View more |